Pancreatic Cancer Research

ResearcherArmy Medical UniversityNo recent work listed

Ping Bie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8512-3186; OpenAlex author ID A5027841986. Sources: OpenAlex.

Their work

Papers
14 (first author 0, last author 8)
Trials
0
Grants
0
Labs led
1
Collaborators
39
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 3 papers · 2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: none · 2019: 3 papers · 2020: 1 paper

Papers 14

  1. LNC00673 suppresses proliferation and metastasis of pancreatic cancer via target miR-504/ HNF1A. Co-author DOI 10.7150/jca.32855↗
  2. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1. Co-author DOI 10.1016/j.phymed.2019.152953↗
  3. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells. Last author DOI 10.1038/s41419-019-1839-z↗
  4. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. Last author DOI 10.1186/s13046-019-1340-7↗
  5. Increased semaphorin 3c expression promotes tumor growth and metastasis in pancreatic ductal adenocarcinoma by activating the ERK1/2 signaling pathway. Last author DOI 10.1016/j.canlet.2017.03.014↗
  6. Association of elevated risk of pancreatic cancer in diabetic patients: A systematic review and meta-analysis. Last author DOI 10.3892/ol.2017.5586↗
  7. MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells. Last author DOI 10.7150/jca.18931↗
  8. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study. Last author DOI 10.1007/s00432-016-2206-4↗
  9. siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo. Co-author DOI 10.1042/bsr20140124↗
  10. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Co-author DOI 10.1016/j.canlet.2013.10.009↗
  11. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells. Last author DOI 10.1016/j.toxlet.2013.10.007↗
  12. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT. Last author DOI 10.1016/j.toxlet.2013.10.008↗
  13. Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective … Co-author DOI 10.1371/journal.pone.0070340↗
  14. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer. Co-author DOI 10.1093/carcin/bgr088↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Haisu Dai · 6 shared papers, 2016–2019 · strength 0.53
  2. Yi Gong · 4 shared papers, 2013–2020 · strength 0.33
  3. Yu You · 5 shared papers, 2014–2017 · strength 0.33
  4. Jiaxin Tan · 4 shared papers, 2014–2017 · strength 0.26
  5. Zhiyu Chen · 2 shared papers, 2019 · strength 0.22
  6. Huaizhi Wang · 4 shared papers, 2013–2017 · strength 0.19
  7. Leida Zhang · 2 shared papers, 2013–2020 · strength 0.17
  8. Xuejun Xu · 2 shared papers, 2017 · strength 0.14
  9. Wei Liu · 1 shared paper, 2020 · strength 0.13
  10. Shixiang Guo · 2 shared papers, 2014–2017 · strength 0.11
  11. Lei-Da Zhang · 2 shared papers, 2014–2015 · strength 0.11
  12. Wei Liu · 1 shared paper, 2019 · strength 0.10
  13. Anbin Wang · 1 shared paper, 2019 · strength 0.10
  14. Xingxing Su · 1 shared paper, 2019 · strength 0.09
  15. Yishi Yang · 1 shared paper, 2019 · strength 0.09
  16. Dingguo Wu · 2 shared papers, 2014 · strength 0.09
  17. Jianhua Xu · 1 shared paper, 2017 · strength 0.08
  18. Bing Ni · 1 shared paper, 2017 · strength 0.07
  19. Zhiping Zhao · 1 shared paper, 2017 · strength 0.07
  20. Jian Li · 1 shared paper, 2017 · strength 0.07
  21. Songsong Liu · 1 shared paper, 2017 · strength 0.07
  22. Peng Jiang · 2 shared papers, 2011–2014 · strength 0.07
  23. Peng Hu · 1 shared paper, 2015 · strength 0.06
  24. Wei Liu · 1 shared paper, 2016 · strength 0.06
  25. Yongsheng Ouyang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.